1. Home
  2. FUNC vs DBVT Comparison

FUNC vs DBVT Comparison

Compare FUNC & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUNC
  • DBVT
  • Stock Information
  • Founded
  • FUNC 1900
  • DBVT 2002
  • Country
  • FUNC United States
  • DBVT France
  • Employees
  • FUNC N/A
  • DBVT N/A
  • Industry
  • FUNC Major Banks
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FUNC Finance
  • DBVT Health Care
  • Exchange
  • FUNC Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • FUNC 202.8M
  • DBVT 237.4M
  • IPO Year
  • FUNC N/A
  • DBVT N/A
  • Fundamental
  • Price
  • FUNC $30.98
  • DBVT $9.09
  • Analyst Decision
  • FUNC
  • DBVT Buy
  • Analyst Count
  • FUNC 0
  • DBVT 4
  • Target Price
  • FUNC N/A
  • DBVT $14.81
  • AVG Volume (30 Days)
  • FUNC 63.1K
  • DBVT 26.9K
  • Earning Date
  • FUNC 07-21-2025
  • DBVT 07-29-2025
  • Dividend Yield
  • FUNC 2.78%
  • DBVT N/A
  • EPS Growth
  • FUNC 61.82
  • DBVT N/A
  • EPS
  • FUNC 3.49
  • DBVT N/A
  • Revenue
  • FUNC $79,403,000.00
  • DBVT $3,497,000.00
  • Revenue This Year
  • FUNC $14.15
  • DBVT $1,700.53
  • Revenue Next Year
  • FUNC $7.07
  • DBVT $535.67
  • P/E Ratio
  • FUNC $9.07
  • DBVT N/A
  • Revenue Growth
  • FUNC 14.92
  • DBVT N/A
  • 52 Week Low
  • FUNC $20.06
  • DBVT $2.21
  • 52 Week High
  • FUNC $42.50
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • FUNC 51.58
  • DBVT 51.86
  • Support Level
  • FUNC $28.00
  • DBVT $8.50
  • Resistance Level
  • FUNC $29.41
  • DBVT $9.69
  • Average True Range (ATR)
  • FUNC 1.12
  • DBVT 0.63
  • MACD
  • FUNC 0.04
  • DBVT -0.03
  • Stochastic Oscillator
  • FUNC 43.62
  • DBVT 44.51

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: